Latest Breaking News On - Castle biosciences inc - Page 19 : comparemela.com

Castle Biosciences to Present at Upcoming Investor Conferences

Castle Biosciences to Present at Upcoming Investor Conferences
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Castle biosciencesCastle biosciences incAbout castleMypath melanomaCastle biosciences stock

Castle Biosciences Reports Third Quarter 2023 Results

FRIENDSWOOD, Texas (BUSINESS WIRE) Nov 2, 2023

United statesMemorial sloan kettering cancer centerNew yorkAllison marshallDerek maetzoldCastle biosciencesCamilla zuckeroCastle biosciences incClinical laboratoryYork state department of healthTop workplaces national industry awardSecurities exchangeMental healthSee the companyQuarter ended septemberPath melanoma

Castle Announces Early Exploratory Study Data for Potential Development of a Complementary Test to Accompany DecisionDx®-UM That Could Aid in the Early Detection of Uveal Melanomas

Renowned eye cancer expert and study investigator, Amy Schefler, M.D., will share early data from a study to explore the potential for developing a complementary test that would be tailored for.

United statesDecisiondx diffdxCastle biosciencesRobert cookCastle bioscienceAmy scheflerAmerican joint committee on cancerUt southwestern medical centerCastle biosciences incNational comprehensive cancer networkMedical centerRetina consultantsUveal melanoma liquid biopsiesAre we goingLoch ness monsterOngoing exploratory study

Castle Biosciences Reports Third Quarter 2023 Results

Q3 2023 revenue increased 66% over Q3 2022 to $61 million Q3 2023 total test reports increased 52% over Q3 2022 Raising full year 2023 revenue guidance to at least $200 million from at least $180.

United statesMemorial sloan kettering cancer centerNew yorkCastle biosciencesDerek maetzoldCastle biosciences incYork state department of healthSecurities exchangeMental healthSee the companyTop workplaces national industry awardClinical laboratoryQuarter ended septemberPath melanomaMonths ended septemberCypher barrett

Early Discovery Data Shows Ability of Castle Biosciences Pipeline Program to Distinguish Between Responders and Non-Responders to an Atopic Dermatitis Therapy

Early Discovery Data Shows Ability of Castle Biosciences Pipeline Program to Distinguish Between Responders and Non-Responders to an Atopic Dermatitis Therapy
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesAaron farbergRobert cookCastle biosciencesSecurities exchangeCastle biosciences incProduct serviceDiscovery data shows abilityCastle bioscience pipeline programDistinguish between respondersAtopic dermatitisBare dermatologyClinical dermatologyMypath melanomaSecurities actSecurities exchange act